- Lobbying
- Lobbying by Novartis Services, Inc.
Lobbying Relationship
Bills mentioned
H.R.6: 21st Century Cures Act
Sponsor: Fred Upton (R-Mich.)
S.2041: Promoting Life-Saving New Therapies for Neonates Act of 2015
Sponsor: Bob Casey (D-Pa.)
H.R.3618: Orphan Drug Fairness Act
Sponsor: Leonard Lance (R-N.J.)
H.R.2: Medicare Access and CHIP Reauthorization Act of 2015
Sponsor: Michael C. Burgess (R-Texas)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Stephen Northrup | HealthPolDirector,Senate HELP Cmte;HealthPolAdv,Sen. Enzi |
Stacey Rampy | LD, Rep. Eshoo; LA, Sen. Torricelli; LA, Sen. Boxer |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate